Muriel B. Huss

Regensburg, BY 93053, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Reciprocal Serum Phosphatidylcholine Signatures Are Related to Intestinal Inflammation in Inflammatory Bowel Disease and Liver Fibrosis in Primary Sclerosing Cholangitis-An Exploratory Study.

Reciprocal Serum Phosphatidylcholine Signatures Are Related to Intestinal Inflammation in Inflammatory Bowel Disease and Liver Fibrosis in Primary Sclerosing Cholangitis-An Exploratory Study.

Journal: Biomedicines

Published: April 22, 2026

Elevated Serum Soluble CD137 in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Highlights a Shared Immunoregulatory Signature.

Elevated Serum Soluble CD137 in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Highlights a Shared Immunoregulatory Signature.

Journal: Biomedicines

Published: April 17, 2026

Decline in Serum Lysophosphatidylcholine Species in Patients with Severe Inflammatory Bowel Disease.

Decline in Serum Lysophosphatidylcholine Species in Patients with Severe Inflammatory Bowel Disease.

Journal: Journal of clinical medicine

Published: June 22, 2025

Serum phosphatidylinositol depletion associates with fecal calprotectin and disease severity in female and male IBD patients.

Serum phosphatidylinositol depletion associates with fecal calprotectin and disease severity in female and male IBD patients.

Journal: Lipids in health and disease

Published: June 22, 2025

Elevated long-to-very-long-chain ceramide ratio correlates with disease severity in inflammatory bowel disease and primary sclerosing cholangitis.

Elevated long-to-very-long-chain ceramide ratio correlates with disease severity in inflammatory bowel disease and primary sclerosing cholangitis.

Journal: Scientific reports

Published: March 31, 2025

Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity.

Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity.

Journal: International journal of molecular sciences

Published: February 04, 2025

Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel Disease.

Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel Disease.

Journal: Pathophysiology : the official journal of the International Society for Pathophysiology

Published: December 03, 2024

Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel Disease.

Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel Disease.

Journal: Biomedicines

Published: November 13, 2024

Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis.

Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis.

Journal: The Journal of steroid biochemistry and molecular biology

Published: June 12, 2024

Interprofessional approach to personalized medication management and therapy optimization in IBD care.

Interprofessional approach to personalized medication management and therapy optimization in IBD care.

Journal: Frontiers in medicine

Published: June 10, 2024

Minimally-invasive tracheostomy (MIT): A care bundle for safety improvement in high-risk critically ill patients.

Minimally-invasive tracheostomy (MIT): A care bundle for safety improvement in high-risk critically ill patients.

Journal: Journal of clinical anesthesia

Published: May 20, 2024

Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis.

Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis.

Journal: International journal of molecular sciences

Published: March 22, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026